ANI Pharmaceuticals

In two facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come!
Baudette, US
Size (employees)
143 (est)+33%
ANI Pharmaceuticals is headquartered in Baudette, US

ANI Pharmaceuticals Office Locations

ANI Pharmaceuticals has office in Baudette
Baudette, US
Baudette, US

ANI Pharmaceuticals Metrics

ANI Pharmaceuticals Summary

Market capitalization

$521.5 m

Closing share price

ANI Pharmaceuticals's current market capitalization is $521.5 m.

ANI Pharmaceuticals Financials

ANI Pharmaceuticals's revenue is $30.1 m in FY, 2013 which is a 46.3% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$30.1 m$56 m$76.3 m$128.6 m

Revenue growth, %


Gross profit

$20.1 m$44.5 m$63.6 m

Operating expense total

$19.2 m$24.5 m$30.9 m


$898 k$20 m$32.7 m

Net Income

$301 k$28.7 m$15.4 m$3.9 m

Operating cash flow

$11.1 m$157.9 m($14.4 m)

ANI Pharmaceuticals Market Value History

ANI Pharmaceuticals Company Life

You may also be interested in